You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Valganciclovir

Showing 1 - 25 of 129
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Transplant Complication, CMV Trial in Charleston (Maribavir, Valganciclovir)

Not yet recruiting
  • Transplant Complication
  • CMV
  • Charleston, South Carolina
    Medical University of South Carolina
Sep 5, 2023

Glioblastoma Trial (RZ-001, VGCV)

Not yet recruiting
  • Glioblastoma
  • (no location specified)
Oct 22, 2023

Kidney Transplant; Complications, CMV Trial (Letermovir 480 mg once daily, Historical/Control)

Not yet recruiting
  • Kidney Transplant; Complications
  • CMV
  • Letermovir 480 mg once daily
  • Historical/Control
  • (no location specified)
Aug 14, 2023

Infections, Cytomegalovirus Trial in Cordoba (Letermovir 240 mg Oral Tablet)

Not yet recruiting
  • Infections, Cytomegalovirus
  • Letermovir 240 mg Oral Tablet
  • Cordoba, Córdoba, Spain
    Hospital Universitario Reina Sofia
Sep 25, 2023

Chronic Fatigue Syndrome Trial in Stanford (valganciclovir)

Completed
  • Chronic Fatigue Syndrome
  • valganciclovir
  • Stanford, California
    Stanford University Medical Center
May 23, 2022

Utilization of Viracor® Assay for Valganciclovir Prophylaxis in

Recruiting
  • Kidney Transplant; Complications
  • Valganciclovir
  • Atlanta, Georgia
    Piedmont Atlanta Hospital
Feb 3, 2022

Hepatocellular Carcinoma Trial in Seoul (RZ-001 Dose 1, RZ-001 Dose 2, RZ-001 Dose 3)

Recruiting
  • Hepatocellular Carcinoma
  • RZ-001 Dose 1
  • +3 more
  • Seoul, Korea, Republic of
    Samsung Medical Center
Oct 25, 2022

Lung Transplant; Complications Trial in New York (device, diagnostic test, drug)

Not yet recruiting
  • Lung Transplant; Complications
  • Cytomegalovirus T Cell Immunity Panel (CMV-TCIP)
  • +2 more
  • New York, New York
    NYU Langone Health
Jan 24, 2023

Glioblastoma Multiforme Trial in Solna (Valganciclovir Tablets, Temozolomide 120 mg, Radiotherapy 60 Gy)

Recruiting
  • Glioblastoma Multiforme
  • Valganciclovir Tablets
  • +3 more
  • Solna, Stockholm, Sweden
    SE01 Karolinska University Hospital
Sep 3, 2021

Kaposi Sarcoma, Human Immunodeficiency Virus, Immune Reconstitution Syndrome Trial in Mexico city (Valganciclovir,

Completed
Has Results
  • Kaposi Sarcoma
  • +2 more
  • Valganciclovir
  • Antiretroviral Combinations
  • Mexico city, Mexico
    Instituto Nacional de Cancerologia
Nov 23, 2021

Congenital Cytomegalovirus Infection Trial in United States (Valganciclovir)

Active, not recruiting
  • Congenital Cytomegalovirus Infection
  • Valganciclovir
  • Birmingham, Alabama
  • +8 more
Aug 18, 2022

Nasopharyngeal Carcinoma, EBV-Related Gastric Carcinoma, EBV-Related Leiomyosarcoma Trial in Worldwide (Nanatinostat,

Recruiting
  • Nasopharyngeal Carcinoma
  • +4 more
  • Lynwood, California
  • +20 more
Jul 27, 2022

Congenital Cytomegaloviral (CMV) Disease Trial in United States (CMV Cytotoxic T-Lymphocytes, Anti-viral Therapy)

Recruiting
  • Congenital Cytomegaloviral (CMV) Disease
  • CMV Cytotoxic T-Lymphocytes
  • Anti-viral Therapy
  • Saint Louis, Missouri
  • +3 more
Oct 24, 2022

Cytomegalovirus Anterior Uveitis Trial in San Francisco (Valganciclovir Hydrochloride, Ganciclovir Sodium, Placebo Oral Tablet)

Recruiting
  • Cytomegalovirus Anterior Uveitis
  • Valganciclovir Hydrochloride
  • +3 more
  • San Francisco, California
    Proctor Foundation, UCSF
Jul 1, 2022

Cytomegalovirus Disease Trial in Los Angeles, Aurora, New Haven (Brincidofovir, Valganciclovir)

Terminated
Has Results
  • Cytomegalovirus Disease
  • Los Angeles, California
  • +2 more
Jun 27, 2021

Cytomegalovirus Disease, Kidney Transplant Infection Trial in Los Angeles, Aurora, New Haven (Brincidofovir, Valganciclovir)

Terminated
Has Results
  • Cytomegalovirus Disease
  • Kidney Transplant Infection
  • Los Angeles, California
  • +2 more
Jun 27, 2021

MDD Trial in Tulsa (Valganciclovir, Placebo)

Recruiting
  • Major Depressive Disorder
  • Valganciclovir
  • Placebo
  • Tulsa, Oklahoma
    Laureate Institute for Brain Research
Feb 13, 2022

Lymphoproliferative Disorder, HHV-8, Malignancy Trial run by the National Cancer Institute (NCI) (Etoposide, Interferon-alpha,

Active, not recruiting
  • Lymphoproliferative Disorder
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Lung Transplant, CMV Trial in Pittsburgh (Letermovir, Valganciclovir)

Recruiting
  • Lung Transplant
  • CMV
  • Pittsburgh, Pennsylvania
  • +1 more
May 16, 2022

Cmv Congenital, CMV, Congenital Cmv Trial in United States (Valganciclovir, Simple Syrup)

Active, not recruiting
  • Cmv Congenital
  • +4 more
  • Valganciclovir
  • Simple Syrup
  • Palo Alto, California
  • +29 more
Feb 22, 2022

Epstein-Barr Virus Associated Lymphoproliferative Disorder, EBV-Related PTLD, EBV Related Non-Hodgkin's Lymphoma Trial in

Recruiting
  • Epstein-Barr Virus Associated Lymphoproliferative Disorder
  • +7 more
  • Nanatinostat in combination with valganciclovir
  • Birmingham, Alabama
  • +57 more
Aug 10, 2022

Kidney Transplant Infection Trial in Córdoba (New profilaxis, Profilaxis recommended)

Completed
  • Kidney Transplant Infection
  • New profilaxis
  • Profilaxis recommended
  • Córdoba, Spain
    Hosìtal Universitario Reina Sofia
Jan 29, 2021

Cytomegalovirus Infection Trial in United States (Valganciclovir)

Completed
Has Results
  • Cytomegalovirus Infection
  • Valganciclovir
  • Los Angeles, California
  • +5 more
Jul 29, 2021

HIV, Cytomegalovirus Infections Trial in San Francisco (Valganciclovir, Placebo)

Completed
Has Results
  • HIV Infections
  • Cytomegalovirus Infections
  • Valganciclovir
  • Placebo
  • San Francisco, California
    San Francisco General Hospital - General Clinical Research Cente
Jul 20, 2020

Cytomegalovirus Infection Trial in United Kingdom, United States (Placebo, Valganciclovir)

Completed
Has Results
  • Cytomegalovirus Infection
  • Placebo
  • Valganciclovir
  • Birmingham, Alabama
  • +17 more
May 6, 2021